Nischarin was so far known as a novel tumor suppressor gene whose downregulation promotes tumorigenesis [13], tumor progression [3, 6, 18], and poor survival in breast, ovarian and lung cancer patients [3, 5, 7, 18]. The gene discussed is NISCH; the disease is lung cancer.